Lv1
30 积分 2024-05-20 加入
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
2天前
已完结
Zanidatamab Is Safe and Efficacious in HER2-Expressing/Amplified Cancers
2天前
求助中
Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
1个月前
已完结
P2.08.46 COPD Reshape the Tumor Microenvironments of NSCLC and Potentiate Antitumor Efficacy of Anti-PD-1 Therapy
1个月前
已关闭
An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells
1个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
1个月前
已完结
Multiple myeloma
1个月前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
1个月前
已完结
Bispecific Antibodies in Solid Tumors: Advances and Challenges
1个月前
已完结
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumours
1个月前
已完结
皖公网安备34019202002308
